IRVINE, Calif., July 31, 2017 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in
patient-focused innovations for structural heart disease and
critical care monitoring, is scheduled to present at the 37th
Annual Canaccord Genuity Growth Conference at the InterContinental
Hotel in Boston, MA on
Wednesday, August 9, 2017.
Scott B. Ullem, Edwards
Lifesciences' chief financial officer, is scheduled to speak to
conference attendees at 10:00 a.m. PT
(1:00 p.m. ET). A live webcast of the
presentation will be available to all interested parties on the
Edwards Lifesciences investor relations website at
http://ir.edwards.com/events.cfm. Following the presentation,
an archived version of the webcast will be available on the Edwards
investor relations website in the News and Events section, and via
the Edwards Lifesciences Investor Relations App for mobile
devices.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine,
Calif., is the global leader in patient-focused medical
innovations for structural heart disease, as well as critical care
and surgical monitoring. Driven by a passion to help patients, the
company collaborates with the world's leading clinicians and
researchers to address unmet healthcare needs, working to improve
patient outcomes and enhance lives. For more information, visit
www.Edwards.com and follow us on Twitter @EdwardsLifesci.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
View original content with
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-37th-annual-canaccord-genuity-growth-conference-300495847.html
SOURCE Edwards Lifesciences Corporation